Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

Clinical trial NCT04670081 · COMPLETED

Trial details

NCT number: NCT04670081
Sponsor: Central Institute of Mental Health, Mannheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment-resistant Depression

Start date: 2021-06-10
Primary completion: 2024-02-27
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.